Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease
about
A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.Neural grafting for Parkinson's disease: challenges and prospects.Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease.Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.Localized vs. Systematic Neurodegeneration: A Paradigm Shift in Understanding Neurodegenerative Diseases.IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.Efficient and Fast Differentiation of Human Neural Stem Cells from Human Embryonic Stem Cells for Cell TherapyCell Therapy for Parkinson's Disease.Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation.BMP/SMAD pathway promotes neurogenesis of midbrain dopaminergic neurons in vivo and in human induced pluripotent and neural stem cells.Towards stem cell based therapies for Parkinson's disease.Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease.Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Neuronal replacement therapy: previous achievements and challenges ahead.Developing defined substrates for stem cell culture and differentiation.Transcriptional synergy as an emergent property defining cell subpopulation identity enables population shift.
P2860
Q38693456-DEB64BBD-8D49-42DB-A549-D3746C47F191Q39282063-D8023D83-DBDF-4C3A-81A0-1D9B2E5DFEB8Q39332126-73C88935-8D04-4548-B68D-2D54947B1515Q41018807-16D25DEF-E00E-4C12-9953-550BBD338B68Q41525515-83B26BC4-698B-472B-80E4-BAABE34BC637Q42376393-909A1FC5-284C-43E9-B480-497458256E16Q42717876-1378EC8F-3279-45A6-8070-A5738D1B0CF5Q45740164-26615C83-5A21-485E-BF4B-A915EF0FCEAEQ45910053-D6CE2EC8-9542-4DC4-A5FE-FBC4740D4CFEQ47734532-2CEFFA6F-C7C7-423E-BE58-2E5EDC9D0875Q47872003-9BD768F6-BA99-4D52-9320-A5D4CD3C3BE7Q47877645-4C05CA7A-6A9D-48C8-A021-722453E3A127Q48132718-C06B9320-8772-47B8-B98C-D72472427709Q52568381-985662DE-07D0-4688-8816-3A50FBC9E0D2Q52589683-9CC7A2E8-C663-4F83-8854-8EB2B76B6A88Q52729618-9674AD50-E83C-43A5-9F2B-3A8765071F36Q55073124-41CDDD91-AC25-4BF3-93EB-AB5F69E945C5Q55518398-21AD93B1-EB3C-4DBF-8D29-EA45C74AC2D7
P2860
Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@ast
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@en
type
label
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@ast
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@en
prefLabel
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@ast
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@en
P2093
P2860
P50
P1433
P1476
Predictive Markers Guide Diffe ...... herapy for Parkinson's Disease
@en
P2093
Daniella Rylander Ottosson
Katarina Tiklova
Thomas Perlmann
P2860
P304
P356
10.1016/J.STEM.2016.09.004
P407
P50
P577
2016-10-27T00:00:00Z